Archana N Dhawan, MD
Nephrology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 4 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 552608 · 552712 · El Camino Health · Good Samaritan Hospital · Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dhawan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
California Medical Board record
Licence A83916 · Current
Licensed to practise in California · since 2003 · expires 2026-10-31 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$166,704
Medicare paid this office $166,704 for 408 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 275 | $84,659 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $23,080 | $106 |
| New patient visit (45+ min) | 83 | $11,784 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $10,974 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $7,460 | $155 |
See all 11 services
| Return visit (30+ min) | 275 | $84,659 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $23,080 | $106 |
| New patient visit (45+ min) | 83 | $11,784 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $10,974 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $7,460 | $155 |
| Long return visit (40+ min) | 20 | $3,580 | $163 |
| Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 12 | $3,051 | $5 |
| Short return visit (20+ min) | 20 | $1,590 | $76 |
| Injection of drug or substance under skin or into muscle | 16 | $833 | $14 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $659 | $44 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 18 | $270 | $15 |
Who their Medicare patients are
408 Original Medicare patients in 2024. Average age 79 · Under 65 4% · 85 and older 28% · Women 50% · Also on Medicaid 16% · Health risk score 2.76. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 59% · Coronary heart disease 52% · Heart failure 46% · Atrial fibrillation 41% · Depression 20% · COPD 19% · Cancer 17% · Dementia 17% · Stroke 14%.
The office billed $590,519, Medicare allowed $220,904 and paid $166,704; for 3,237 services of 22 kinds; $3,772 of it was for drugs given in the office and $162,932 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 408 | 3,237 | 79 | 2.76 | $590,519 | $166,704 |
| 2023 | 402 | 2,792 | 78 | 3.17 | $587,809 | $168,544 |
| 2022 | 342 | 2,256 | 78 | 3.05 | $554,945 | $162,224 |
| 2021 | 301 | 1,103 | 77 | 2.86 | $354,100 | $115,114 |
| 2020 | 352 | 1,218 | 78 | 3.33 | $383,013 | $108,946 |
| 2019 | 386 | 1,603 | 78 | 3.22 | $484,265 | $140,250 |
| 2018 | 434 | 1,564 | 79 | 2.87 | $484,494 | $140,457 |
| 2017 | 369 | 1,407 | 78 | 3.06 | $544,898 | $128,709 |
| 2016 | 305 | 1,257 | 76 | 3.15 | $341,125 | $120,038 |
| 2015 | 293 | 1,186 | 78 | 2.87 | $169,648 | $121,247 |
| 2014 | 254 | 1,064 | 76 | 3.16 | $164,568 | $116,833 |
| 2013 | 302 | 1,427 | 77 | 2.93 | $213,401 | $148,131 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 223 | $60,628 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $22,489 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 98 | $16,416 | $73 |
| Long return visit (40+ min) | 42 | $9,366 | $159 |
| New patient visit (45+ min) | 54 | $8,018 | $148 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $7,997 | $160 |
| Critical care, first 30-74 minutes | 13 | $5,963 | $192 |
| Short return visit (20+ min) | 42 | $4,146 | $83 |
| Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 13 | $4,017 | $6 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $1,490 | $45 |
| Injection of drug or substance under skin or into muscle | 14 | $1,122 | $14 |
2022: 11 services
| Return visit (30+ min) | 196 | $62,198 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $19,024 | $95 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $15,922 | $194 |
| Long return visit (40+ min) | 46 | $9,304 | $139 |
| New patient visit (45+ min) | 54 | $8,395 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $7,919 | $66 |
| Critical care, first 30-74 minutes | 11 | $6,082 | $196 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,041 | $183 |
| Short return visit (20+ min) | 39 | $4,673 | $75 |
| New patient visit (60+ min) | 17 | $3,238 | $190 |
| Injection of drug or substance under skin or into muscle | 14 | $1,044 | $14 |
2021: 10 services
| Return visit (30+ min) | 169 | $51,060 | $115 |
| Dialysis services, 1 physician visit per month (20 years or older) | 16 | $13,249 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $12,901 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $10,009 | $65 |
| Long return visit (40+ min) | 26 | $5,134 | $166 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,959 | $184 |
| New patient visit (45+ min) | 23 | $3,725 | $162 |
| Short return visit (20+ min) | 33 | $3,672 | $87 |
| New patient visit (60+ min) | 14 | $2,992 | $214 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,029 | $94 |
2020: 10 services
| Return visit (30+ min) | 147 | $31,325 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $18,936 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $13,834 | $95 |
| Short return visit (20+ min) | 110 | $11,986 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $8,084 | $184 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $6,126 | $123 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $4,743 | $169 |
| New patient visit (45+ min) | 18 | $2,519 | $140 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,645 | $103 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $1,069 | $34 |
2019: 11 services
| Return visit (30+ min) | 154 | $33,556 | $96 |
| Short return visit (20+ min) | 177 | $26,161 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 113 | $17,582 | $65 |
| Dialysis services, 1 physician visit per month (20 years or older) | 23 | $16,598 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $15,634 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,958 | $178 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $5,250 | $122 |
| New patient visit (45+ min) | 30 | $4,158 | $139 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,347 | $98 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $1,577 | $35 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $611 | $51 |
2018: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $23,981 | $63 |
| Short return visit (20+ min) | 156 | $18,642 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $18,091 | $89 |
| Dialysis services, 1 physician visit per month (20 years or older) | 25 | $17,664 | $156 |
| Return visit (30+ min) | 112 | $16,218 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $15,957 | $173 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,689 | $119 |
| Long return visit (40+ min) | 26 | $5,220 | $116 |
| Hospital discharge day management, more than 30 minutes | 48 | $4,694 | $96 |
| New patient visit (60+ min) | 16 | $2,971 | $186 |
| New patient visit (45+ min) | 16 | $1,802 | $113 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,085 | $34 |
| Short return visit | 19 | $703 | $35 |
2017: 15 services
| Return visit (30+ min) | 134 | $21,732 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 129 | $21,062 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $17,588 | $168 |
| Dialysis services, 1 physician visit per month (20 years or older) | 25 | $15,757 | $153 |
| Short return visit (20+ min) | 135 | $13,105 | $59 |
| Long return visit (40+ min) | 35 | $8,070 | $124 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $5,116 | $114 |
| New patient visit (45+ min) | 32 | $4,532 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $4,367 | $86 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $4,043 | $202 |
| New patient visit (60+ min) | 11 | $1,949 | $177 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,646 | $91 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,041 | $33 |
| Short return visit | 17 | $639 | $38 |
| Administration of influenza virus vaccine | 13 | $420 | $32 |
2016: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $18,231 | $89 |
| Return visit (30+ min) | 103 | $18,164 | $91 |
| Dialysis services, 1 physician visit per month (20 years or older) | 21 | $15,809 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 100 | $14,141 | $62 |
| Short return visit (20+ min) | 110 | $11,499 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,695 | $173 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 59 | $7,934 | $117 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 13 | $5,427 | $209 |
| Long return visit (40+ min) | 15 | $4,138 | $129 |
| New patient visit (45+ min) | 21 | $3,066 | $146 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,121 | $93 |
| Short return visit | 15 | $639 | $40 |
2015: 13 services
| Return visit (30+ min) | 123 | $25,462 | $96 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $21,451 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $14,434 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $10,544 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 69 | $8,806 | $119 |
| Long return visit (40+ min) | 31 | $8,130 | $129 |
| Short return visit (20+ min) | 69 | $7,452 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,058 | $176 |
| New patient visit (45+ min) | 38 | $5,648 | $149 |
| Hospital discharge day management, more than 30 minutes | 25 | $2,570 | $95 |
| New patient visit (60+ min) | 12 | $2,106 | $175 |
| Administration of influenza virus vaccine | 15 | $477 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 15 | $189 | $13 |
2014: 12 services
| Return visit (30+ min) | 129 | $24,956 | $95 |
| Dialysis services, 1 physician visit per month (20 years or older) | 23 | $24,808 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $12,384 | $92 |
| Long return visit (40+ min) | 43 | $12,319 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $9,672 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,375 | $180 |
| Critical care, first 30-74 minutes | 14 | $5,864 | $195 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $4,260 | $122 |
| Short return visit (20+ min) | 46 | $4,197 | $63 |
| New patient visit (60+ min) | 11 | $2,072 | $188 |
| New patient visit (45+ min) | 12 | $1,821 | $152 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,255 | $97 |
2013: 13 services
| Return visit (30+ min) | 140 | $29,283 | $95 |
| Long return visit (40+ min) | 79 | $24,210 | $124 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $20,820 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $17,267 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 93 | $15,363 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $13,949 | $170 |
| New patient visit (60+ min) | 28 | $5,134 | $183 |
| New patient visit (45+ min) | 32 | $4,733 | $148 |
| Short return visit (20+ min) | 46 | $3,976 | $64 |
| Hospital discharge day management, more than 30 minutes | 33 | $3,181 | $94 |
| Critical care, first 30-74 minutes | 11 | $2,999 | $187 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,447 | $117 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 16 | $891 | $49 |
Medicaid work
$1,049 in 2021
Medicaid paid $1,049 for 75 billed services this clinician did in 2021, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 75 | $1,049 |
| 2021 | 75 | 1 | 17 | $1,049 |
Drugs they prescribed that Part D paid
$460,781
Pharmacies billed $460,781 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,421 generic and fewer than 11 brand-name prescriptions · $460,781 in drug cost · 64 antibiotic prescriptions to 33 people · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 70 | $93,764 | $1,339 |
| Farxiga | 54 | $72,976 | $1,351 |
| Kerendia | 26 | $41,021 | $1,578 |
| Rayaldee | 12 | $27,970 | $2,331 |
| Ozempic | 24 | $22,265 | $928 |
See all 63 drugs
| Jardiance | 70 | $93,764 | $1,339 |
| Farxiga | 54 | $72,976 | $1,351 |
| Kerendia | 26 | $41,021 | $1,578 |
| Rayaldee | 12 | $27,970 | $2,331 |
| Ozempic | 24 | $22,265 | $928 |
| Veltassa | 17 | $22,158 | $1,303 |
| Lokelma | 29 | $21,754 | $750 |
| Eliquis | 16 | $12,954 | $810 |
| Sevelamer Carbonate | 48 | $9,437 | $197 |
| Repatha Sureclick | 13 | $7,014 | $540 |
| Auryxia | 11 | $6,457 | $587 |
| Bumetanide | 182 | $5,599 | $31 |
| Xarelto | 11 | $5,344 | $486 |
| Febuxostat | 26 | $3,966 | $153 |
| Calcitriol | 151 | $2,798 | $19 |
| Procrit | 11 | $2,627 | $239 |
| Vascepa | 11 | $1,992 | $181 |
| Famotidine | 82 | $1,616 | $20 |
| Potassium Chloride | 26 | $1,579 | $61 |
| Losartan | 121 | $1,558 | $13 |
| Hydralazine | 95 | $1,437 | $15 |
| Amlodipine Besylate | 173 | $1,380 | $8 |
| Furosemide | 135 | $1,191 | $9 |
| Olmesartan Medoxomil | 56 | $1,136 | $20 |
| Calcium Acetate | 20 | $1,035 | $52 |
| Metoprolol | 66 | $1,016 | $15 |
| Rosuvastatin | 70 | $1,006 | $14 |
| Telmisartan | 16 | $981 | $61 |
| Nebivolol | 12 | $955 | $80 |
| Nifedipine Er | 30 | $928 | $31 |
| Olanzapine | 13 | $871 | $67 |
| Fluvastatin | 13 | $839 | $65 |
| Allopurinol | 86 | $818 | $10 |
| Levothyroxine | 63 | $793 | $13 |
| Tamsulosin | 40 | $658 | $16 |
| Chlorthalidone | 36 | $619 | $17 |
| Atorvastatin | 41 | $611 | $15 |
| Spironolactone | 38 | $560 | $15 |
| Repaglinide | 15 | $558 | $37 |
| Lisinopril | 56 | $508 | $9 |
| Olmesartan-Hydrochlorothiazide | 22 | $492 | $22 |
| Mirtazapine | 24 | $490 | $20 |
| Pantoprazole | 23 | $467 | $20 |
| Megestrol Acetate | 12 | $464 | $39 |
| Carvedilol | 35 | $404 | $12 |
| Omega-3 Acid Ethyl Esters | 11 | $372 | $34 |
| Loperamide | 13 | $363 | $28 |
| Valsartan-Hydrochlorothiazide | 13 | $348 | $27 |
| Gabapentin | 28 | $298 | $11 |
| Escitalopram | 21 | $293 | $14 |
| Metformin | 14 | $238 | $17 |
| Cephalexin | 23 | $219 | $10 |
| Hydrochlorothiazide | 48 | $217 | $5 |
| Prednisone | 20 | $199 | $10 |
| Glimepiride | 13 | $196 | $15 |
| Clonidine | 12 | $174 | $15 |
| Citalopram Hbr | 19 | $158 | $8 |
| Nitrofurantoin Mono-Macro | 13 | $142 | $11 |
| Trazodone | 18 | $114 | $6 |
| Terazosin | 11 | $108 | $10 |
| Simvastatin | 11 | $52 | $5 |
| Atenolol | 12 | $36 | $3 |
| Ciprofloxacin | 13 | $36 | $3 |
Year by year
| 2024 | 2,898 | 298 | None | None | $460,781 |
| 2023 | 2,392 | 256 | None | 16% | $371,460 |
| 2022 | 2,108 | 238 | None | None | $277,174 |
| 2021 | 2,618 | 256 | None | None | $282,983 |
| 2020 | 2,724 | 249 | 1% (16) | None | $363,830 |
| 2019 | 2,728 | 245 | 1% (23) | None | $365,599 |
| 2018 | 2,631 | 239 | 2% (40) | 21% | $337,523 |
| 2017 | 2,591 | 215 | 2% (56) | 22% | $388,272 |
| 2016 | 2,822 | 212 | 2% (61) | 21% | $412,727 |
| 2015 | 2,971 | 198 | 3% (83) | 24% | $418,278 |
| 2014 | 3,126 | 205 | 5% (148) | 28% | $360,472 |
| 2013 | 3,195 | 216 | 3% (104) | 31% | $307,701 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 55 drugs
| Farxiga | 39 | $57,700 | $1,479 |
| Jardiance | 42 | $54,675 | $1,302 |
| Kerendia | 20 | $28,583 | $1,429 |
| Januvia | 16 | $23,261 | $1,454 |
| Eliquis | 18 | $20,936 | $1,163 |
| Lokelma | 21 | $16,957 | $807 |
| Rayaldee | 12 | $15,479 | $1,290 |
| Auryxia | 12 | $9,811 | $818 |
| Sevelamer Carbonate | 20 | $9,421 | $471 |
| Veltassa | 11 | $9,363 | $851 |
| Febuxostat | 30 | $5,154 | $172 |
| Bumetanide | 120 | $4,293 | $36 |
| Calcitriol | 146 | $2,959 | $20 |
| Nebivolol | 13 | $2,546 | $196 |
| Nifedipine Er | 47 | $2,487 | $53 |
| Losartan | 88 | $1,748 | $20 |
| Amlodipine Besylate | 136 | $1,658 | $12 |
| Hydralazine | 64 | $1,512 | $24 |
| Metoprolol | 67 | $1,492 | $22 |
| Rosuvastatin | 55 | $1,306 | $24 |
| Calcium Acetate | 15 | $1,109 | $74 |
| Furosemide | 133 | $972 | $7 |
| Tamsulosin | 31 | $971 | $31 |
| Atorvastatin | 33 | $920 | $28 |
| Levothyroxine | 59 | $897 | $15 |
| Telmisartan | 11 | $831 | $76 |
| Carvedilol | 35 | $809 | $23 |
| Olmesartan Medoxomil | 50 | $712 | $14 |
| Pantoprazole | 23 | $679 | $30 |
| Allopurinol | 61 | $660 | $11 |
| Citalopram Hbr | 21 | $657 | $31 |
| Famotidine | 23 | $645 | $28 |
| Valsartan-Hydrochlorothiazide | 20 | $636 | $32 |
| Lisinopril | 48 | $612 | $13 |
| Potassium Chloride | 12 | $594 | $50 |
| Omega-3 Acid Ethyl Esters | 14 | $561 | $40 |
| Hydrochlorothiazide | 36 | $518 | $14 |
| Repaglinide | 18 | $498 | $28 |
| Olmesartan-Hydrochlorothiazide | 11 | $473 | $43 |
| Glimepiride | 25 | $419 | $17 |
| Chlorthalidone | 18 | $361 | $20 |
| Simvastatin | 21 | $310 | $15 |
| Mirtazapine | 15 | $260 | $17 |
| Gabapentin | 21 | $237 | $11 |
| Diclofenac | 13 | $235 | $18 |
| Spironolactone | 23 | $216 | $9 |
| Cephalexin | 28 | $216 | $8 |
| Duloxetine | 14 | $213 | $15 |
| Ropinirole | 12 | $201 | $17 |
| Metoprolol | 13 | $190 | $15 |
| Alendronate | 13 | $150 | $12 |
| Glipizide | 15 | $124 | $8 |
| Losartan-Hydrochlorothiazide | 13 | $116 | $9 |
| Prednisone | 11 | $97 | $9 |
| Ciprofloxacin | 19 | $84 | $4 |
2022: 44 drugs
| Jardiance | 25 | $30,975 | $1,239 |
| Farxiga | 30 | $28,871 | $962 |
| Januvia | 15 | $25,093 | $1,673 |
| Sevelamer Carbonate | 22 | $7,577 | $344 |
| Febuxostat | 39 | $6,639 | $170 |
| Bumetanide | 85 | $6,235 | $73 |
| Breo Ellipta | 11 | $4,055 | $369 |
| Nifedipine Er | 44 | $3,183 | $72 |
| Rosuvastatin | 56 | $2,450 | $44 |
| Nebivolol | 13 | $2,427 | $187 |
| Omega-3 Acid Ethyl Esters | 12 | $2,374 | $198 |
| Calcitriol | 107 | $2,061 | $19 |
| Losartan | 79 | $1,369 | $17 |
| Olmesartan-Hydrochlorothiazide | 14 | $1,272 | $91 |
| Amlodipine Besylate | 113 | $1,239 | $11 |
| Hydralazine | 45 | $1,165 | $26 |
| Metoprolol | 59 | $1,094 | $19 |
| Potassium Chloride | 19 | $1,029 | $54 |
| Furosemide | 141 | $988 | $7 |
| Levothyroxine | 45 | $848 | $19 |
| Duloxetine | 23 | $740 | $32 |
| Olmesartan Medoxomil | 38 | $719 | $19 |
| Pregabalin | 11 | $693 | $63 |
| Allopurinol | 50 | $691 | $14 |
| Losartan-Hydrochlorothiazide | 15 | $641 | $43 |
| Atorvastatin | 35 | $616 | $18 |
| Carvedilol | 39 | $599 | $15 |
| Tamsulosin | 30 | $593 | $20 |
| Famotidine | 25 | $589 | $24 |
| Glimepiride | 37 | $542 | $15 |
| Hydrochlorothiazide | 60 | $418 | $7 |
| Omeprazole | 15 | $411 | $27 |
| Doxazosin Mesylate | 13 | $341 | $26 |
| Chlorthalidone | 11 | $323 | $29 |
| Pantoprazole | 17 | $323 | $19 |
| Lisinopril | 39 | $315 | $8 |
| Simvastatin | 21 | $290 | $14 |
| Cephalexin | 24 | $234 | $10 |
| Fluticasone Propionate | 11 | $203 | $18 |
| Nitrofurantoin Mono-Macro | 15 | $202 | $13 |
| Prednisone | 16 | $171 | $11 |
| Metoprolol | 17 | $162 | $10 |
| Enalapril Maleate | 11 | $126 | $11 |
| Glipizide | 13 | $110 | $8 |
2021: 62 drugs
| Procrit | 28 | $18,346 | $655 |
| Vascepa | 30 | $15,916 | $531 |
| Tradjenta | 12 | $15,494 | $1,291 |
| Prosol | 75 | $12,720 | $170 |
| Linzess | 12 | $11,006 | $917 |
| Sevelamer Carbonate | 38 | $9,591 | $252 |
| Bystolic | 15 | $7,484 | $499 |
| Invokana | 13 | $7,147 | $550 |
| Febuxostat | 23 | $6,021 | $262 |
| Bumetanide | 53 | $4,752 | $90 |
| Breo Ellipta | 11 | $3,955 | $360 |
| Nifedipine Er | 47 | $3,933 | $84 |
| Retacrit | 23 | $3,770 | $164 |
| Rosuvastatin | 71 | $3,156 | $44 |
| Calcitriol | 95 | $2,922 | $31 |
| Omega-3 Acid Ethyl Esters | 17 | $1,790 | $105 |
| Potassium Chloride | 27 | $1,704 | $63 |
| Levothyroxine | 77 | $1,676 | $22 |
| Calcium Acetate | 17 | $1,670 | $98 |
| Acyclovir | 11 | $1,616 | $147 |
| Olmesartan Medoxomil | 33 | $1,382 | $42 |
| Losartan | 74 | $1,353 | $18 |
| Amlodipine Besylate | 123 | $1,348 | $11 |
| Rivastigmine | 11 | $1,272 | $116 |
| Fenofibrate | 19 | $1,129 | $59 |
| Atorvastatin | 63 | $1,051 | $17 |
| Furosemide | 113 | $897 | $8 |
| Allopurinol | 63 | $867 | $14 |
| Pantoprazole | 29 | $833 | $29 |
| Tamsulosin | 39 | $794 | $20 |
| Metoprolol | 34 | $773 | $23 |
| Hydralazine | 28 | $758 | $27 |
| Losartan-Hydrochlorothiazide | 23 | $711 | $31 |
| Gabapentin | 33 | $649 | $20 |
| Carvedilol | 46 | $617 | $13 |
| Simvastatin | 62 | $613 | $10 |
| Chlorthalidone | 16 | $599 | $37 |
| Hydrochlorothiazide | 56 | $551 | $10 |
| Glimepiride | 31 | $549 | $18 |
| Omeprazole | 21 | $537 | $26 |
| Enalapril Maleate | 23 | $436 | $19 |
| Diclofenac | 14 | $371 | $26 |
| Valsartan-Hydrochlorothiazide | 16 | $354 | $22 |
| Pravastatin | 13 | $354 | $27 |
| Lisinopril | 39 | $353 | $9 |
| Escitalopram | 15 | $340 | $23 |
| Metoprolol | 30 | $334 | $11 |
| Cephalexin | 37 | $329 | $9 |
| Alendronate | 16 | $307 | $19 |
| Metformin | 28 | $254 | $9 |
| Ketoconazole | 15 | $252 | $17 |
| Clonidine | 18 | $198 | $11 |
| Gentamicin Sulfate | 11 | $156 | $14 |
| Lisinopril-Hydrochlorothiazide | 12 | $154 | $13 |
| Bupropion Xl | 12 | $143 | $12 |
| Prednisone | 19 | $133 | $7 |
| Spironolactone | 13 | $132 | $10 |
| Clopidogrel | 12 | $103 | $9 |
| Levocetirizine Dihydrochloride | 12 | $102 | $9 |
| Zolpidem | 18 | $80 | $4 |
| Ciprofloxacin | 11 | $57 | $5 |
| Lorazepam | 13 | $47 | $4 |
2020: 69 drugs
| Rayaldee | 30 | $40,648 | $1,355 |
| Procrit | 61 | $36,544 | $599 |
| Tradjenta | 15 | $20,204 | $1,347 |
| Vascepa | 45 | $19,774 | $439 |
| Sevelamer Carbonate | 37 | $18,893 | $511 |
| Januvia | 22 | $18,209 | $828 |
| Prosol | 73 | $18,133 | $248 |
| Invokana | 25 | $14,629 | $585 |
| Linzess | 13 | $13,437 | $1,034 |
| Febuxostat | 22 | $11,155 | $507 |
| Veltassa | 14 | $10,617 | $758 |
| Bystolic | 20 | $9,146 | $457 |
| Bumetanide | 60 | $4,665 | $78 |
| Calcitriol | 102 | $3,491 | $34 |
| Nifedipine Er | 33 | $2,975 | $90 |
| Wixela Inhub | 16 | $2,622 | $164 |
| Levothyroxine | 99 | $2,578 | $26 |
| Rosuvastatin | 39 | $1,747 | $45 |
| Potassium Chloride | 29 | $1,669 | $58 |
| Losartan-Hydrochlorothiazide | 26 | $1,536 | $59 |
| Amlodipine Besylate | 109 | $1,486 | $14 |
| Rivastigmine | 11 | $1,383 | $126 |
| Clonidine | 11 | $1,309 | $119 |
| Allopurinol | 76 | $1,183 | $16 |
| Atorvastatin | 74 | $1,138 | $15 |
| Pantoprazole | 35 | $1,105 | $32 |
| Furosemide | 105 | $1,073 | $10 |
| Olmesartan Medoxomil | 15 | $1,067 | $71 |
| Albuterol Sulfate Hfa | 12 | $1,048 | $87 |
| Fenofibrate | 14 | $1,017 | $73 |
| Metoprolol | 36 | $916 | $25 |
| Losartan | 55 | $813 | $15 |
| Duloxetine | 11 | $773 | $70 |
| Valsartan-Hydrochlorothiazide | 24 | $750 | $31 |
| Pravastatin | 18 | $700 | $39 |
| Simvastatin | 63 | $672 | $11 |
| Gabapentin | 33 | $627 | $19 |
| Carbidopa-Levodopa | 14 | $595 | $42 |
| Diclofenac | 18 | $594 | $33 |
| Glimepiride | 37 | $580 | $16 |
| Lidocaine-Prilocaine | 12 | $534 | $44 |
| Enalapril Maleate | 14 | $527 | $38 |
| Hydralazine | 20 | $497 | $25 |
| Carvedilol | 53 | $481 | $9 |
| Doxazosin Mesylate | 15 | $477 | $32 |
| Escitalopram | 20 | $442 | $22 |
| Tamsulosin | 24 | $421 | $18 |
| Lisinopril | 41 | $404 | $10 |
| Hydrochlorothiazide | 43 | $351 | $8 |
| Bupropion Xl | 15 | $350 | $23 |
| Omeprazole | 19 | $342 | $18 |
| Metformin | 36 | $322 | $9 |
| Fluticasone Propionate | 12 | $321 | $27 |
| Nystop | 17 | $307 | $18 |
| Triamcinolone Acetonide | 15 | $273 | $18 |
| Metoprolol | 25 | $233 | $9 |
| Alendronate | 18 | $233 | $13 |
| Nitrofurantoin Mono-Macro | 17 | $223 | $13 |
| Famotidine | 13 | $189 | $15 |
| Spironolactone | 19 | $189 | $10 |
| Zolpidem | 26 | $167 | $6 |
| Clonidine | 14 | $160 | $11 |
| Prednisone | 20 | $135 | $7 |
| Cephalexin | 17 | $115 | $7 |
| Levocetirizine Dihydrochloride | 12 | $102 | $9 |
| Glipizide | 11 | $99 | $9 |
| Clopidogrel | 14 | $86 | $6 |
| Azithromycin | 16 | $81 | $5 |
| Ciprofloxacin | 12 | $63 | $5 |
2019: 68 drugs
| Rayaldee | 54 | $66,281 | $1,227 |
| Procrit | 33 | $25,629 | $777 |
| Januvia | 26 | $23,578 | $907 |
| Veltassa | 22 | $17,732 | $806 |
| Tradjenta | 14 | $16,439 | $1,174 |
| Vascepa | 35 | $12,043 | $344 |
| Sevelamer Carbonate | 26 | $9,860 | $379 |
| Invokana | 12 | $6,253 | $521 |
| Colcrys | 11 | $5,359 | $487 |
| Nifedipine Er | 53 | $3,423 | $65 |
| Calcitriol | 108 | $3,064 | $28 |
| Levothyroxine | 103 | $2,924 | $28 |
| Bumetanide | 35 | $2,601 | $74 |
| Prosol | 11 | $2,176 | $198 |
| Duloxetine | 21 | $2,123 | $101 |
| Rosuvastatin | 28 | $1,819 | $65 |
| Atorvastatin | 88 | $1,815 | $21 |
| Potassium Chloride | 15 | $1,687 | $112 |
| Amlodipine Besylate | 126 | $1,585 | $13 |
| Allopurinol | 81 | $1,560 | $19 |
| Clonidine | 13 | $1,350 | $104 |
| Furosemide | 127 | $1,326 | $10 |
| Pantoprazole | 49 | $1,295 | $26 |
| Metoprolol | 31 | $1,034 | $33 |
| Ezetimibe | 12 | $906 | $76 |
| Irbesartan | 15 | $851 | $57 |
| Pravastatin | 23 | $759 | $33 |
| Escitalopram | 39 | $752 | $19 |
| Diclofenac | 20 | $741 | $37 |
| Doxazosin Mesylate | 14 | $720 | $51 |
| Gabapentin | 34 | $663 | $20 |
| Losartan-Hydrochlorothiazide | 43 | $651 | $15 |
| Losartan | 56 | $642 | $11 |
| Trazodone | 28 | $600 | $21 |
| Carvedilol | 42 | $592 | $14 |
| Cephalexin | 17 | $564 | $33 |
| Celecoxib | 18 | $564 | $31 |
| Glimepiride | 23 | $531 | $23 |
| Simvastatin | 60 | $526 | $9 |
| Tamsulosin | 16 | $520 | $32 |
| Nitrofurantoin Mono-Macro | 19 | $435 | $23 |
| Valsartan-Hydrochlorothiazide | 17 | $415 | $24 |
| Gentamicin Sulfate | 13 | $408 | $31 |
| Hydroxyzine | 17 | $394 | $23 |
| Nystop | 21 | $382 | $18 |
| Omeprazole | 21 | $344 | $16 |
| Hydralazine | 15 | $338 | $23 |
| Metformin | 33 | $334 | $10 |
| Lisinopril | 37 | $329 | $9 |
| Hydrochlorothiazide | 35 | $310 | $9 |
| Bupropion Xl | 13 | $307 | $24 |
| Triamcinolone Acetonide | 23 | $298 | $13 |
| Amoxicillin-Clavulanate Potass | 22 | $280 | $13 |
| Metoprolol | 27 | $246 | $9 |
| Zolpidem | 34 | $225 | $7 |
| Glipizide Er | 12 | $214 | $18 |
| Acyclovir | 11 | $204 | $19 |
| Lovastatin | 13 | $171 | $13 |
| Clopidogrel | 15 | $170 | $11 |
| Azithromycin | 19 | $138 | $7 |
| Glipizide | 16 | $137 | $9 |
| Ciprofloxacin | 21 | $137 | $7 |
| Hydrocodone-Acetaminophen | 15 | $128 | $9 |
| Clonidine | 11 | $116 | $11 |
| Levocetirizine Dihydrochloride | 12 | $102 | $9 |
| Prednisone | 15 | $100 | $7 |
| Alprazolam | 13 | $34 | $3 |
| Lorazepam | 13 | $33 | $3 |
2018: 70 drugs
| Rayaldee | 32 | $41,628 | $1,301 |
| Renvela | 12 | $30,761 | $2,563 |
| Procrit | 43 | $29,212 | $679 |
| Sevelamer Carbonate | 21 | $19,581 | $932 |
| Januvia | 17 | $18,045 | $1,061 |
| Advair Diskus | 15 | $11,661 | $777 |
| Linzess | 11 | $11,392 | $1,036 |
| Lyrica | 12 | $9,484 | $790 |
| Eliquis | 17 | $8,870 | $522 |
| Tradjenta | 12 | $7,408 | $617 |
| Vascepa | 17 | $4,825 | $284 |
| Calcitriol | 138 | $4,686 | $34 |
| Dexilant | 12 | $3,523 | $294 |
| Prosol | 19 | $3,161 | $166 |
| Atorvastatin | 97 | $2,732 | $28 |
| Levothyroxine | 90 | $2,597 | $29 |
| Nifedipine Er | 27 | $1,834 | $68 |
| Amlodipine Besylate | 126 | $1,660 | $13 |
| Fenofibrate | 27 | $1,503 | $56 |
| Ventolin Hfa | 13 | $1,410 | $108 |
| Duloxetine | 14 | $1,355 | $97 |
| Allopurinol | 69 | $1,347 | $20 |
| Furosemide | 131 | $1,215 | $9 |
| Bumetanide | 23 | $1,168 | $51 |
| Metoprolol | 30 | $1,108 | $37 |
| Hydrocodone-Acetaminophen | 24 | $1,083 | $45 |
| Enalapril Maleate | 17 | $897 | $53 |
| Valsartan | 15 | $883 | $59 |
| Losartan | 71 | $882 | $12 |
| Chlorthalidone | 14 | $865 | $62 |
| Celecoxib | 13 | $860 | $66 |
| Pantoprazole | 45 | $795 | $18 |
| Omeprazole | 27 | $750 | $28 |
| Calcium Acetate | 13 | $717 | $55 |
| Metolazone | 13 | $714 | $55 |
| Escitalopram | 27 | $674 | $25 |
| Diclofenac | 15 | $638 | $43 |
| Simvastatin | 52 | $636 | $12 |
| Glimepiride | 25 | $626 | $25 |
| Rosuvastatin | 12 | $583 | $49 |
| Tamsulosin | 12 | $567 | $47 |
| Megestrol Acetate | 19 | $547 | $29 |
| Pravastatin | 25 | $506 | $20 |
| Valsartan-Hydrochlorothiazide | 20 | $489 | $24 |
| Metformin | 43 | $488 | $11 |
| Lisinopril | 54 | $488 | $9 |
| Ranitidine | 16 | $481 | $30 |
| Glipizide Er | 13 | $427 | $33 |
| Ramipril | 15 | $414 | $28 |
| Losartan-Hydrochlorothiazide | 23 | $403 | $18 |
| Carvedilol | 50 | $401 | $8 |
| Gabapentin | 32 | $352 | $11 |
| Zolpidem | 35 | $296 | $8 |
| Nitrofurantoin Mono-Macro | 13 | $289 | $22 |
| Metoprolol | 31 | $275 | $9 |
| Venlafaxine Hcl Er | 15 | $266 | $18 |
| Nystop | 14 | $263 | $19 |
| Hydrochlorothiazide | 29 | $231 | $8 |
| Trazodone | 13 | $227 | $17 |
| Hydralazine | 12 | $211 | $18 |
| Lorazepam | 19 | $199 | $10 |
| Cephalexin | 30 | $170 | $6 |
| Triamcinolone Acetonide | 14 | $162 | $12 |
| Ciprofloxacin | 21 | $157 | $7 |
| Prednisone | 12 | $130 | $11 |
| Azithromycin | 22 | $124 | $6 |
| Glipizide | 16 | $115 | $7 |
| Clonidine | 15 | $100 | $7 |
| Metoclopramide | 12 | $93 | $8 |
| Clonazepam | 12 | $75 | $6 |
2017: 66 drugs
| Renvela | 26 | $64,395 | $2,477 |
| Sensipar | 21 | $44,878 | $2,137 |
| Rayaldee | 17 | $24,250 | $1,426 |
| Procrit | 23 | $13,861 | $603 |
| Linzess | 14 | $11,834 | $845 |
| Tradjenta | 21 | $11,749 | $559 |
| Eliquis | 18 | $9,273 | $515 |
| Victoza 2-Pak | 11 | $7,232 | $657 |
| Veltassa | 16 | $6,949 | $434 |
| Vascepa | 21 | $5,808 | $277 |
| Calcium Acetate | 43 | $3,764 | $88 |
| Calcitriol | 119 | $3,618 | $30 |
| Bystolic | 16 | $2,790 | $174 |
| Levothyroxine | 84 | $2,662 | $32 |
| Duloxetine | 27 | $2,326 | $86 |
| Valsartan | 38 | $2,171 | $57 |
| Atorvastatin | 81 | $1,881 | $23 |
| Nifedipine Er | 27 | $1,772 | $66 |
| Ventolin Hfa | 25 | $1,752 | $70 |
| Bumetanide | 35 | $1,681 | $48 |
| Amlodipine Besylate | 110 | $1,339 | $12 |
| Fenofibrate | 20 | $1,250 | $63 |
| Metoprolol | 29 | $1,089 | $38 |
| Allopurinol | 63 | $1,081 | $17 |
| Hydralazine | 28 | $880 | $31 |
| Carvedilol | 73 | $880 | $12 |
| Pravastatin | 39 | $793 | $20 |
| Pantoprazole | 41 | $769 | $19 |
| Repaglinide | 15 | $640 | $43 |
| Furosemide | 104 | $628 | $6 |
| Tamsulosin | 26 | $615 | $24 |
| Valsartan-Hydrochlorothiazide | 14 | $602 | $43 |
| Losartan | 61 | $592 | $10 |
| Enalapril Maleate | 20 | $566 | $28 |
| Celecoxib | 17 | $522 | $31 |
| Hydrocodone-Acetaminophen | 27 | $496 | $18 |
| Megestrol Acetate | 18 | $482 | $27 |
| Omeprazole | 23 | $464 | $20 |
| Escitalopram | 13 | $421 | $32 |
| Simvastatin | 38 | $400 | $11 |
| Clonidine | 23 | $352 | $15 |
| Doxazosin Mesylate | 11 | $343 | $31 |
| Lisinopril | 33 | $341 | $10 |
| Glipizide Er | 12 | $337 | $28 |
| Nitrofurantoin Mono-Macro | 11 | $329 | $30 |
| Ramipril | 13 | $303 | $23 |
| Ranitidine | 13 | $297 | $23 |
| Metformin | 26 | $280 | $11 |
| Ciprofloxacin | 40 | $276 | $7 |
| Losartan-Hydrochlorothiazide | 19 | $266 | $14 |
| Glipizide Xl | 12 | $266 | $22 |
| Venlafaxine Hcl Er | 20 | $260 | $13 |
| Prednisone | 23 | $246 | $11 |
| Hydrochlorothiazide | 30 | $231 | $8 |
| Cephalexin | 27 | $224 | $8 |
| Paroxetine | 11 | $220 | $20 |
| Gabapentin | 27 | $208 | $8 |
| Triamcinolone Acetonide | 11 | $199 | $18 |
| Lorazepam | 21 | $191 | $9 |
| Metoprolol | 35 | $189 | $5 |
| Tramadol | 22 | $164 | $7 |
| Amoxicillin-Clavulanate Potass | 18 | $160 | $9 |
| Azithromycin | 22 | $156 | $7 |
| Zolpidem | 22 | $129 | $6 |
| Glimepiride | 13 | $114 | $9 |
| Glipizide | 13 | $79 | $6 |
2016: 81 drugs
| Sensipar | 40 | $82,538 | $2,063 |
| Renvela | 37 | $78,628 | $2,125 |
| Procrit | 30 | $19,452 | $648 |
| Januvia | 16 | $16,517 | $1,032 |
| Lyrica | 15 | $13,749 | $917 |
| Linzess | 16 | $11,343 | $709 |
| Tradjenta | 12 | $9,708 | $809 |
| Uloric | 15 | $8,113 | $541 |
| Victoza 2-Pak | 13 | $6,570 | $505 |
| Veltassa | 11 | $6,142 | $558 |
| Benicar | 16 | $5,545 | $347 |
| Omega-3 Acid Ethyl Esters | 15 | $5,124 | $342 |
| Duloxetine | 35 | $4,399 | $126 |
| Bystolic | 15 | $3,998 | $267 |
| Calcitriol | 153 | $3,701 | $24 |
| Lidocaine | 15 | $3,700 | $247 |
| Calcium Acetate | 30 | $3,235 | $108 |
| Clonidine | 12 | $2,236 | $186 |
| Amitiza | 12 | $1,989 | $166 |
| Valsartan | 40 | $1,983 | $50 |
| Levothyroxine | 67 | $1,872 | $28 |
| Nifedipine Er | 32 | $1,861 | $58 |
| Fenofibrate | 28 | $1,697 | $61 |
| Hydrocodone-Acetaminophen | 37 | $1,573 | $43 |
| Nifedical Xl | 27 | $1,457 | $54 |
| Hydralazine | 55 | $1,423 | $26 |
| Repaglinide | 18 | $1,334 | $74 |
| Amlodipine Besylate | 109 | $1,245 | $11 |
| Atorvastatin | 68 | $1,230 | $18 |
| Tamsulosin | 31 | $1,141 | $37 |
| Bumetanide | 27 | $1,049 | $39 |
| Allopurinol | 63 | $1,038 | $16 |
| Carvedilol | 57 | $894 | $16 |
| Pantoprazole | 48 | $840 | $17 |
| Metoprolol | 28 | $830 | $30 |
| Furosemide | 133 | $829 | $6 |
| Omeprazole | 35 | $812 | $23 |
| Bd Ultra-Fine Pen Needle | 26 | $779 | $30 |
| Verapamil | 12 | $749 | $62 |
| Enalapril Maleate | 26 | $710 | $27 |
| Ventolin Hfa | 11 | $678 | $62 |
| Acyclovir | 14 | $643 | $46 |
| Oxycodone-Acetaminophen | 15 | $642 | $43 |
| Pravastatin | 22 | $635 | $29 |
| Triamcinolone Acetonide | 27 | $629 | $23 |
| Isosorbide Mononitrate Er | 33 | $600 | $18 |
| Losartan | 54 | $538 | $10 |
| Labetalol | 24 | $483 | $20 |
| Valsartan-Hydrochlorothiazide | 12 | $446 | $37 |
| Lorazepam | 23 | $436 | $19 |
| Glipizide Er | 23 | $427 | $19 |
| Simvastatin | 40 | $395 | $10 |
| Lisinopril | 33 | $395 | $12 |
| Gabapentin | 31 | $383 | $12 |
| Escitalopram | 16 | $379 | $24 |
| Cefdinir | 12 | $300 | $25 |
| Venlafaxine Hcl Er | 24 | $295 | $12 |
| Megestrol Acetate | 18 | $284 | $16 |
| Ciprofloxacin | 30 | $284 | $9 |
| Cephalexin | 31 | $282 | $9 |
| Zolpidem | 26 | $256 | $10 |
| Clonidine | 34 | $252 | $7 |
| Metoprolol | 45 | $246 | $5 |
| Metformin | 18 | $223 | $12 |
| Losartan-Hydrochlorothiazide | 16 | $213 | $13 |
| Spironolactone | 17 | $210 | $12 |
| Amiodarone | 11 | $205 | $19 |
| Paroxetine | 11 | $190 | $17 |
| Olanzapine | 13 | $172 | $13 |
| Triamterene-Hydrochlorothiazid | 14 | $159 | $11 |
| Hydrochlorothiazide | 33 | $158 | $5 |
| Azithromycin | 19 | $150 | $8 |
| Minoxidil | 12 | $128 | $11 |
| Clopidogrel | 15 | $124 | $8 |
| Levofloxacin | 13 | $115 | $9 |
| Prednisone | 15 | $111 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $95 | $9 |
| Sertraline | 11 | $86 | $8 |
| Clonazepam | 14 | $83 | $6 |
| Glipizide | 17 | $77 | $5 |
| Atenolol | 13 | $69 | $5 |
2015: 80 drugs
| Renvela | 59 | $90,855 | $1,540 |
| Sensipar | 41 | $77,122 | $1,881 |
| Procrit | 26 | $16,591 | $638 |
| Victoza 2-Pak | 21 | $10,898 | $519 |
| Januvia | 21 | $10,464 | $498 |
| Lyrica | 11 | $9,004 | $819 |
| Tradjenta | 12 | $8,115 | $676 |
| Omega-3 Acid Ethyl Esters | 32 | $8,077 | $252 |
| Lantus Solostar | 14 | $7,719 | $551 |
| Linzess | 18 | $7,340 | $408 |
| Crestor | 12 | $6,279 | $523 |
| Bystolic | 30 | $5,758 | $192 |
| Advair Diskus | 13 | $5,752 | $442 |
| Calcium Acetate | 47 | $5,582 | $119 |
| Duloxetine | 21 | $4,479 | $213 |
| Plavix | 16 | $4,477 | $280 |
| Benicar | 12 | $3,731 | $311 |
| Valsartan | 33 | $3,612 | $109 |
| Clonidine | 11 | $3,109 | $283 |
| Amitiza | 17 | $2,990 | $176 |
| Escitalopram | 20 | $2,740 | $137 |
| Calcitriol | 129 | $2,716 | $21 |
| Levothyroxine | 65 | $2,011 | $31 |
| Fenofibrate | 23 | $1,951 | $85 |
| Nifedipine Er | 40 | $1,902 | $48 |
| Repaglinide | 20 | $1,864 | $93 |
| Hydrocodone-Acetaminophen | 45 | $1,477 | $33 |
| Atorvastatin | 56 | $1,240 | $22 |
| Isosorbide Mononitrate Er | 49 | $1,203 | $25 |
| Amlodipine Besylate | 118 | $1,128 | $10 |
| Nifedical Xl | 20 | $1,127 | $56 |
| Metoprolol | 32 | $1,116 | $35 |
| Proair Hfa | 16 | $1,112 | $69 |
| Tamsulosin | 26 | $1,065 | $41 |
| Bd Ultra-Fine Pen Needle | 34 | $974 | $29 |
| Allopurinol | 67 | $962 | $14 |
| Potassium Chloride | 25 | $959 | $38 |
| Furosemide | 161 | $906 | $6 |
| Valsartan-Hydrochlorothiazide | 26 | $895 | $34 |
| Bumetanide | 14 | $877 | $63 |
| Hydralazine | 38 | $850 | $22 |
| Oxycodone-Acetaminophen | 16 | $812 | $51 |
| Carvedilol | 50 | $727 | $15 |
| Pantoprazole | 32 | $644 | $20 |
| Pravastatin | 18 | $618 | $34 |
| Losartan | 48 | $612 | $13 |
| Verapamil | 11 | $570 | $52 |
| Megestrol Acetate | 26 | $501 | $19 |
| Lorazepam | 27 | $487 | $18 |
| Omeprazole | 38 | $475 | $13 |
| Glipizide Er | 21 | $470 | $22 |
| Clonidine | 44 | $407 | $9 |
| Simvastatin | 57 | $389 | $7 |
| Labetalol | 13 | $372 | $29 |
| Lisinopril | 35 | $369 | $11 |
| Gabapentin | 34 | $362 | $11 |
| Clopidogrel | 32 | $352 | $11 |
| Glipizide Xl | 12 | $351 | $29 |
| Famotidine | 30 | $338 | $11 |
| Amiodarone | 18 | $337 | $19 |
| Minoxidil | 19 | $299 | $16 |
| Triamcinolone Acetonide | 17 | $272 | $16 |
| Hydrochlorothiazide | 34 | $261 | $8 |
| Metoprolol | 53 | $245 | $5 |
| Venlafaxine Hcl Er | 21 | $242 | $12 |
| Cephalexin | 31 | $211 | $7 |
| Zolpidem | 26 | $202 | $8 |
| Olanzapine | 12 | $175 | $15 |
| Ondansetron | 12 | $171 | $14 |
| Atenolol | 18 | $154 | $9 |
| Levofloxacin | 15 | $142 | $9 |
| Metformin | 15 | $141 | $9 |
| Diazepam | 16 | $140 | $9 |
| Azithromycin | 20 | $139 | $7 |
| Ciprofloxacin | 26 | $135 | $5 |
| Lisinopril-Hydrochlorothiazide | 14 | $116 | $8 |
| Tramadol | 13 | $103 | $8 |
| Spironolactone | 14 | $103 | $7 |
| Glipizide | 21 | $78 | $4 |
| Clonazepam | 17 | $76 | $4 |
2014: 74 drugs
| Renvela | 58 | $60,870 | $1,049 |
| Procrit | 38 | $37,429 | $985 |
| Sensipar | 27 | $36,666 | $1,358 |
| Januvia | 36 | $14,874 | $413 |
| Prosol | 32 | $11,729 | $367 |
| Crestor | 30 | $9,812 | $327 |
| Diovan | 35 | $8,872 | $253 |
| Lantus Solostar | 21 | $6,885 | $328 |
| Lovaza | 26 | $5,800 | $223 |
| Coreg Cr | 11 | $5,302 | $482 |
| Colcrys | 16 | $5,282 | $330 |
| Calcium Acetate | 46 | $5,215 | $113 |
| Calcitriol | 78 | $3,647 | $47 |
| Nifedipine Er | 41 | $2,930 | $71 |
| Plavix | 11 | $2,858 | $260 |
| Omega-3 Acid Ethyl Esters | 12 | $2,654 | $221 |
| Valsartan-Hydrochlorothiazide | 34 | $2,509 | $74 |
| Fenofibrate | 14 | $2,293 | $164 |
| Repaglinide | 16 | $2,202 | $138 |
| Metoprolol | 42 | $2,110 | $50 |
| Nifedical Xl | 18 | $1,995 | $111 |
| Isosorbide Mononitrate Er | 50 | $1,680 | $34 |
| Bystolic | 15 | $1,665 | $111 |
| Hydrocodone-Acetaminophen | 77 | $1,581 | $21 |
| Amlodipine Besylate | 152 | $1,521 | $10 |
| Dextrose in Water | 32 | $1,360 | $43 |
| Atorvastatin | 56 | $1,333 | $24 |
| Escitalopram | 19 | $1,272 | $67 |
| Proair Hfa | 19 | $1,132 | $60 |
| Hydralazine | 42 | $1,096 | $26 |
| Carvedilol | 78 | $1,089 | $14 |
| Levothyroxine | 40 | $1,024 | $26 |
| Bd Ultra-Fine Pen Needle | 28 | $998 | $36 |
| Pravastatin | 17 | $904 | $53 |
| Furosemide | 172 | $841 | $5 |
| Clopidogrel | 39 | $839 | $22 |
| Temazepam | 22 | $835 | $38 |
| Potassium Chloride | 21 | $787 | $37 |
| Losartan | 50 | $749 | $15 |
| Glipizide Er | 21 | $717 | $34 |
| Pantoprazole | 33 | $679 | $21 |
| Megestrol Acetate | 25 | $663 | $27 |
| Omeprazole | 51 | $632 | $12 |
| Tamsulosin | 25 | $602 | $24 |
| Glipizide Xl | 17 | $536 | $32 |
| Verapamil | 11 | $486 | $44 |
| Simvastatin | 54 | $486 | $9 |
| Minoxidil | 26 | $481 | $19 |
| Clonidine | 53 | $477 | $9 |
| Allopurinol | 52 | $472 | $9 |
| Lisinopril | 50 | $465 | $9 |
| Meclizine | 15 | $461 | $31 |
| Triamcinolone Acetonide | 34 | $444 | $13 |
| Famotidine | 36 | $404 | $11 |
| Gabapentin | 47 | $389 | $8 |
| Zolpidem | 43 | $359 | $8 |
| Hydrochlorothiazide | 43 | $353 | $8 |
| Klor-Con 8 | 12 | $346 | $29 |
| Venlafaxine Hcl Er | 14 | $333 | $24 |
| Alendronate | 20 | $331 | $17 |
| Glipizide | 38 | $320 | $8 |
| Metoprolol | 63 | $268 | $4 |
| Lorazepam | 25 | $231 | $9 |
| Sertraline | 30 | $225 | $8 |
| Tramadol | 33 | $201 | $6 |
| Benazepril | 16 | $183 | $11 |
| Azithromycin | 24 | $175 | $7 |
| Spironolactone | 15 | $158 | $11 |
| Diazepam | 19 | $140 | $7 |
| Ciprofloxacin | 26 | $133 | $5 |
| Clonazepam | 22 | $130 | $6 |
| Cyclobenzaprine | 11 | $123 | $11 |
| Warfarin | 15 | $100 | $7 |
| Cephalexin | 11 | $49 | $4 |
2013: 82 drugs
| Renvela | 73 | $45,775 | $627 |
| Procrit | 36 | $31,950 | $888 |
| Januvia | 60 | $24,228 | $404 |
| Sensipar | 20 | $14,894 | $745 |
| Diovan | 45 | $9,717 | $216 |
| Prosol | 27 | $7,445 | $276 |
| Calcitriol | 146 | $6,955 | $48 |
| Coreg Cr | 18 | $6,858 | $381 |
| Prandin | 18 | $6,357 | $353 |
| Lantus Solostar | 22 | $6,308 | $287 |
| Lovaza | 32 | $5,789 | $181 |
| Crestor | 19 | $5,494 | $289 |
| Calcium Acetate | 50 | $5,418 | $108 |
| Repaglinide | 13 | $4,496 | $346 |
| Advair Diskus | 16 | $4,253 | $266 |
| Spiriva | 15 | $4,187 | $279 |
| Bystolic | 15 | $3,522 | $235 |
| Valsartan-Hydrochlorothiazide | 23 | $3,185 | $138 |
| Plavix | 13 | $2,573 | $198 |
| Atorvastatin | 64 | $2,499 | $39 |
| Exforge | 12 | $2,166 | $180 |
| Metoprolol | 34 | $2,140 | $63 |
| Nateglinide | 18 | $1,630 | $91 |
| Clopidogrel | 33 | $1,543 | $47 |
| Amlodipine Besylate | 120 | $1,477 | $12 |
| Nifedipine Er | 26 | $1,418 | $55 |
| Isosorbide Mononitrate Er | 50 | $1,385 | $28 |
| Nifedical Xl | 13 | $1,298 | $100 |
| Glipizide Er | 26 | $1,198 | $46 |
| Furosemide | 187 | $1,119 | $6 |
| Carvedilol | 76 | $990 | $13 |
| Sps | 11 | $949 | $86 |
| Losartan | 24 | $904 | $38 |
| Proair Hfa | 13 | $880 | $68 |
| Bd Ultra-Fine Pen Needle | 23 | $853 | $37 |
| Pioglitazone | 12 | $836 | $70 |
| Potassium Chloride | 17 | $813 | $48 |
| Megestrol Acetate | 30 | $812 | $27 |
| Hydralazine | 30 | $790 | $26 |
| Pantoprazole | 45 | $784 | $17 |
| Tamsulosin | 29 | $751 | $26 |
| Omeprazole | 46 | $709 | $15 |
| Hydrocodone-Acetaminophen | 53 | $704 | $13 |
| Levothyroxine | 57 | $693 | $12 |
| Temazepam | 16 | $673 | $42 |
| Escitalopram | 17 | $634 | $37 |
| Famotidine | 57 | $625 | $11 |
| Simvastatin | 60 | $555 | $9 |
| Glipizide | 55 | $543 | $10 |
| Lisinopril | 59 | $533 | $9 |
| Clonidine | 44 | $471 | $11 |
| Pravastatin | 20 | $463 | $23 |
| Allopurinol | 54 | $395 | $7 |
| Metoprolol | 52 | $394 | $8 |
| Hydrochlorothiazide | 45 | $391 | $9 |
| Klor-Con 8 | 13 | $327 | $25 |
| Alendronate | 23 | $320 | $14 |
| Sertraline | 39 | $304 | $8 |
| Doxazosin Mesylate | 15 | $271 | $18 |
| Zolpidem | 48 | $268 | $6 |
| Benazepril | 20 | $252 | $13 |
| Warfarin | 20 | $248 | $12 |
| Azithromycin | 25 | $240 | $10 |
| Minoxidil | 15 | $204 | $14 |
| Levofloxacin | 14 | $194 | $14 |
| Lisinopril-Hydrochlorothiazide | 12 | $181 | $15 |
| Ciprofloxacin | 35 | $170 | $5 |
| Gabapentin | 23 | $169 | $7 |
| Venlafaxine Hcl Er | 12 | $146 | $12 |
| Lorazepam | 20 | $143 | $7 |
| Oxybutynin Chloride | 13 | $135 | $10 |
| Triamcinolone Acetonide | 12 | $128 | $11 |
| Tramadol | 23 | $128 | $6 |
| Cyclobenzaprine | 11 | $125 | $11 |
| Metoclopramide | 15 | $122 | $8 |
| Spironolactone | 11 | $117 | $11 |
| Cephalexin | 18 | $115 | $6 |
| Clonazepam | 14 | $103 | $7 |
| Atenolol | 11 | $100 | $9 |
| Diazepam | 14 | $86 | $6 |
| Glimepiride | 14 | $83 | $6 |
| Prednisone | 12 | $49 | $4 |
Money from drug and device companies
$398 in 2025
| 2025 | 3 | 3 | None | $398 |
| 2023 | 2 | 2 | None | $294 |
| 2022 | 3 | 5 | None | $207 |
| 2021 | 5 | 15 | None | $467 |
| 2020 | 3 | 3 | None | $62 |
| 2019 | 7 | 8 | None | $465 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vantive US Healthcare | Renal - Pd | $143 | 1 payment
|
| Travere Therapeutics | Filspari | $130 | 1 payment
|
| Otsuka America Pharmaceutical | Voyxact | $125 | 1 payment
|
See all 3 published payments
| Otsuka America Pharmaceutical | Meals · 2025-12-09 | Voyxact | $125 |
| Travere Therapeutics | Meals · 2025-11-12 | Filspari | $130 |
| Vantive US Healthcare | Meals · 2025-09-17 | Renal - Pd | $143 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $294
| La Jolla Pharmaceutical | Giapreza | $187 | 1 payment
|
| Travere Therapeutics | None | $107 | 1 payment
|
2022: $207
| Bayer HealthCare Pharmaceuticals | Kerendia | $140 | 3 payments
|
| Amgen | Tavneos | $55 | 1 payment
|
| Vifor Pharma | None | $12 | 1 payment
|
2021: $467
| Mallinckrodt Hospital Products | Acthar | $168 | 6 payments
|
| Amgen | Parsabiv | $126 | 5 payments
|
| Novo Nordisk | Rybelsus | $113 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $33 | 2 payments
|
| Abbott Laboratories | Mitraclip System | $27 | 1 payment
|
2020: $62
| Mallinckrodt Hospital Products | Acthar | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $22 | 1 payment
|
| GlaxoSmithKline | Benlysta | $14 | 1 payment
|
2019: $465
| Amgen | Parsabiv | $125 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $119 | 1 payment
|
| Baxter Healthcare | Renal - Pd | $100 | 1 payment
|
| Janssen Pharmaceuticals | Invokana | $44 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $30 | 1 payment
|
| Medtronic Vascular | Endurant | $26 | 1 payment
|
| Relypsa | Veltassa | $21 | 1 payment
|
Professional record
- NPI
- 1649294273
- Licence
- CA A83916California A83916: Current · expires 2026-10-31
- Trained
- Saint Louis University School of Medicine, 2001
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-27
- NPI last updated
- 2021-09-28
- NPI record certified
- 2021-09-28
This is when the NPI record was last certified, not a medical board exam.